Selected research
Market Structure
Global Probenecid Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Probenecid Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Probenecid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Probenecid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Probenecid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Probenecid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Probenecid Tablets include Shanghai Sine Pharmaceutical, Sunflower Pharmaceutical Group, Jinling Pharmaceutical, Watson Pharmaceuticals, Teva, Salvavidas Pharmaceutical, Rising Pharma, Lannett Company and Geno Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Probenecid Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Probenecid Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Probenecid Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Probenecid Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Probenecid Tablets Segment by Company
Shanghai Sine Pharmaceutical
Sunflower Pharmaceutical Group
Jinling Pharmaceutical
Watson Pharmaceuticals
Teva
Salvavidas Pharmaceutical
Rising Pharma
Lannett Company
Geno Pharmaceuticals
Probenecid Tablets Segment by Type
0.50g per Tablet
0.25g per Tablet
Probenecid Tablets Segment by Application
Retail Pharmacies
Hospitals and Clinics
Other
Probenecid Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probenecid Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Probenecid Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probenecid Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Probenecid Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Probenecid Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Probenecid Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Probenecid Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 0.50g per Tablet
- 0.25g per Tablet
Applications
- Retail Pharmacies
- Hospitals and Clinics
- Other
Companies covered
- Shanghai Sine Pharmaceutical
- Sunflower Pharmaceutical Group
- Jinling Pharmaceutical
- Watson Pharmaceuticals
- Teva
- Salvavidas Pharmaceutical
- Rising Pharma
- Lannett Company
- Geno Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Probenecid Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Probenecid Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Probenecid Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Probenecid Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Probenecid Tablets Market Dynamics
- 2.1 Probenecid Tablets Industry Trends
- 2.2 Probenecid Tablets Industry Drivers
- 2.3 Probenecid Tablets Industry Opportunities and Challenges
- 2.4 Probenecid Tablets Industry Restraints
3 Probenecid Tablets Market by Manufacturers
- 3.1 Global Probenecid Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Probenecid Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Probenecid Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Probenecid Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Probenecid Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Probenecid Tablets Manufacturers, Product Type & Application
- 3.7 Global Probenecid Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Probenecid Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Probenecid Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Probenecid Tablets Tier 1, Tier 2, and Tier 3
4 Probenecid Tablets Market by Type
- 4.1 Probenecid Tablets Type Introduction
- 4.1.1 0.50g per Tablet
- 4.1.2 0.25g per Tablet
- 4.2 Global Probenecid Tablets Sales by Type
- 4.2.1 Global Probenecid Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Probenecid Tablets Sales by Type (2021-2032)
- 4.2.3 Global Probenecid Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Probenecid Tablets Revenue by Type
- 4.3.1 Global Probenecid Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Probenecid Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Probenecid Tablets Revenue Market Share by Type (2021-2032)
5 Probenecid Tablets Market by Application
- 5.1 Probenecid Tablets Application Introduction
- 5.1.1 Retail Pharmacies
- 5.1.2 Hospitals and Clinics
- 5.1.3 Other
- 5.2 Global Probenecid Tablets Sales by Application
- 5.2.1 Global Probenecid Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Probenecid Tablets Sales by Application (2021-2032)
- 5.2.3 Global Probenecid Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Probenecid Tablets Revenue by Application
- 5.3.1 Global Probenecid Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Probenecid Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Probenecid Tablets Revenue Market Share by Application (2021-2032)
6 Global Probenecid Tablets Sales by Region
- 6.1 Global Probenecid Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Probenecid Tablets Sales by Region (2021-2032)
- 6.2.1 Global Probenecid Tablets Sales by Region (2021-2026)
- 6.2.2 Global Probenecid Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Probenecid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Probenecid Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Probenecid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Probenecid Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Probenecid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Probenecid Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Probenecid Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Probenecid Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Probenecid Tablets Revenue by Region
- 7.1 Global Probenecid Tablets Revenue by Region
- 7.1.1 Global Probenecid Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Probenecid Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Probenecid Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Probenecid Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Probenecid Tablets Revenue (2021-2032)
- 7.2.2 North America Probenecid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Probenecid Tablets Revenue (2021-2032)
- 7.3.2 Europe Probenecid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Probenecid Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Probenecid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Probenecid Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Probenecid Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Shanghai Sine Pharmaceutical
- 8.1.1 Shanghai Sine Pharmaceutical Company Information
- 8.1.2 Shanghai Sine Pharmaceutical Business Overview
- 8.1.3 Shanghai Sine Pharmaceutical Probenecid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Shanghai Sine Pharmaceutical Probenecid Tablets Product Portfolio
- 8.1.5 Shanghai Sine Pharmaceutical Recent Developments
- 8.2 Sunflower Pharmaceutical Group
- 8.2.1 Sunflower Pharmaceutical Group Company Information
- 8.2.2 Sunflower Pharmaceutical Group Business Overview
- 8.2.3 Sunflower Pharmaceutical Group Probenecid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sunflower Pharmaceutical Group Probenecid Tablets Product Portfolio
- 8.2.5 Sunflower Pharmaceutical Group Recent Developments
- 8.3 Jinling Pharmaceutical
- 8.3.1 Jinling Pharmaceutical Company Information
- 8.3.2 Jinling Pharmaceutical Business Overview
- 8.3.3 Jinling Pharmaceutical Probenecid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jinling Pharmaceutical Probenecid Tablets Product Portfolio
- 8.3.5 Jinling Pharmaceutical Recent Developments
- 8.4 Watson Pharmaceuticals
- 8.4.1 Watson Pharmaceuticals Company Information
- 8.4.2 Watson Pharmaceuticals Business Overview
- 8.4.3 Watson Pharmaceuticals Probenecid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Watson Pharmaceuticals Probenecid Tablets Product Portfolio
- 8.4.5 Watson Pharmaceuticals Recent Developments
- 8.5 Teva
- 8.5.1 Teva Company Information
- 8.5.2 Teva Business Overview
- 8.5.3 Teva Probenecid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Teva Probenecid Tablets Product Portfolio
- 8.5.5 Teva Recent Developments
- 8.6 Salvavidas Pharmaceutical
- 8.6.1 Salvavidas Pharmaceutical Company Information
- 8.6.2 Salvavidas Pharmaceutical Business Overview
- 8.6.3 Salvavidas Pharmaceutical Probenecid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Salvavidas Pharmaceutical Probenecid Tablets Product Portfolio
- 8.6.5 Salvavidas Pharmaceutical Recent Developments
- 8.7 Rising Pharma
- 8.7.1 Rising Pharma Company Information
- 8.7.2 Rising Pharma Business Overview
- 8.7.3 Rising Pharma Probenecid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Rising Pharma Probenecid Tablets Product Portfolio
- 8.7.5 Rising Pharma Recent Developments
- 8.8 Lannett Company
- 8.8.1 Lannett Company Company Information
- 8.8.2 Lannett Company Business Overview
- 8.8.3 Lannett Company Probenecid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Lannett Company Probenecid Tablets Product Portfolio
- 8.8.5 Lannett Company Recent Developments
- 8.9 Geno Pharmaceuticals
- 8.9.1 Geno Pharmaceuticals Company Information
- 8.9.2 Geno Pharmaceuticals Business Overview
- 8.9.3 Geno Pharmaceuticals Probenecid Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Geno Pharmaceuticals Probenecid Tablets Product Portfolio
- 8.9.5 Geno Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Probenecid Tablets Value Chain Analysis
- 9.1.1 Probenecid Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Probenecid Tablets Production Mode & Process
- 9.2 Probenecid Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Probenecid Tablets Distributors
- 9.2.3 Probenecid Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst